Cameroon's multidrug-resistant tuberculosis treatment programme jeopardised by cross-border migration

Affiliations

¹ Clinic of Infectious and Tropical Diseases, University of Brescia, Brescia, Italy.
² The Global TB Programme, World Health Organization, Geneva, Switzerland Dept of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden.
³ Migration Health Dept, International Organization of Migration, Geneva, Switzerland.
⁴ The Global TB Programme, World Health Organization, Geneva, Switzerland.
⁵ WHO Collaborating Center for TB and Lung Diseases Fondazione S. Maugeri, Tradate, Italy.
⁶ WHO Collaborating Center for TB and Lung Diseases Fondazione S. Maugeri, Tradate, Italy Public Health Consulting Group, Lugano, Switzerland.
⁷ WHO Collaborating Center for TB and Lung Diseases Fondazione S. Maugeri, Tradate, Italy giovannibattista.migliori@fsm.it.

Free article

Comment

Alberto Matteelli et al. Eur Respir J. 2016 Feb.

Free article

. 2016 Feb;47(2):686-8.

doi: 10.1183/13993003.01597-2015.

¹ Clinic of Infectious and Tropical Diseases, University of Brescia, Brescia, Italy.
² The Global TB Programme, World Health Organization, Geneva, Switzerland Dept of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden.
³ Migration Health Dept, International Organization of Migration, Geneva, Switzerland.
⁴ The Global TB Programme, World Health Organization, Geneva, Switzerland.
⁵ WHO Collaborating Center for TB and Lung Diseases Fondazione S. Maugeri, Tradate, Italy.
⁶ WHO Collaborating Center for TB and Lung Diseases Fondazione S. Maugeri, Tradate, Italy Public Health Consulting Group, Lugano, Switzerland.
⁷ WHO Collaborating Center for TB and Lung Diseases Fondazione S. Maugeri, Tradate, Italy giovannibattista.migliori@fsm.it.

No abstract available

Comment on

Towards tuberculosis elimination: an action framework for low-incidence countries.
Lönnroth K, Migliori GB, Abubakar I, D'Ambrosio L, de Vries G, Diel R, Douglas P, Falzon D, Gaudreau MA, Goletti D, González Ochoa ER, LoBue P, Matteelli A, Njoo H, Solovic I, Story A, Tayeb T, van der Werf MJ, Weil D, Zellweger JP, Abdel Aziz M, Al Lawati MR, Aliberti S, Arrazola de Oñate W, Barreira D, Bhatia V, Blasi F, Bloom A, Bruchfeld J, Castelli F, Centis R, Chemtob D, Cirillo DM, Colorado A, Dadu A, Dahle UR, De Paoli L, Dias HM, Duarte R, Fattorini L, Gaga M, Getahun H, Glaziou P, Goguadze L, Del Granado M, Haas W, Järvinen A, Kwon GY, Mosca D, Nahid P, Nishikiori N, Noguer I, O'Donnell J, Pace-Asciak A, Pompa MG, Popescu GG, Robalo Cordeiro C, Rønning K, Ruhwald M, Sculier JP, Simunović A, Smith-Palmer A, Sotgiu G, Sulis G, Torres-Duque CA, Umeki K, Uplekar M, van Weezenbeek C, Vasankari T, Vitillo RJ, Voniatis C, Wanlin M, Raviglione MC. Lönnroth K, et al. Eur Respir J. 2015 Apr;45(4):928-52. doi: 10.1183/09031936.00214014. Eur Respir J. 2015. PMID: 25792630 Free PMC article. Review.
Cameroon's MDR-TB treatment programme jeopardised by cross-border migration.
Noeske J, Foe JL, Kuaban C. Noeske J, et al. Eur Respir J. 2016 Feb;47(2):684-6. doi: 10.1183/13993003.01324-2015. Eur Respir J. 2016. PMID: 26828058 No abstract available.